Related Experiment Video
Updated: Mar 9, 2026

Author Spotlight: Unveiling the Pathway Linking Obesity to Autoimmune Inflammation in Multiple Sclerosis
Published on: February 23, 2024
Obesity and Multiple Sclerosis Susceptibility: A Review
Milena A Gianfrancesco1, Lisa F Barcellos1
1Division of Epidemiology, School of Public Health, University of California, Berkeley, Berkeley, CA, USA.
Childhood and adolescent obesity increase multiple sclerosis (MS) risk, particularly in females. Recent evidence confirms a causal link, highlighting the need for further research into obesity
Area of Science:
- Investigates the intersection of obesity, genetics, and environmental factors in the context of neurological disorders.
Background:
- Growing evidence links early-life obesity to increased susceptibility to multiple sclerosis (MS).
- The association between obesity and MS risk is well-established in females but less consistent in males.
- A potential causal relationship between increased body mass index (BMI) and MS has been recently proposed.
Purpose of the Study:
- To review and synthesize current findings on the significant association between obesity and MS.
- To explore the interplay of BMI with genetic and environmental factors in MS pathogenesis.
- To identify key areas for future research in understanding obesity's role in MS.
Main Methods:
- Comprehensive literature review of studies published over the last decade.
- Analysis of epidemiological data and genetic association studies.
- Synthesis of evidence supporting a causal link between obesity and MS.
Main Results:
- Consistent evidence demonstrates that obesity in childhood and adolescence is a significant risk factor for MS.
- The association is more pronounced in females compared to males.
- Emerging evidence supports a causal relationship between elevated BMI and MS susceptibility.
Conclusions:
- Obesity is a critical factor influencing MS risk, especially when established during early life stages.
- Further investigation is warranted to elucidate the mechanisms underlying the obesity-MS connection and its sex-specific differences.
- Understanding these interactions is crucial for developing targeted prevention and intervention strategies for MS.
Related Concept Videos
Obesity
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution
Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion
Bulimia Nervosa
Genome-wide Association Studies-GWAS
GWAS does not require the identification of the target gene involved in...
Drug Dosing: Obese Patients

